一则是宣布与合作方ETHK Group共同投资成立两家新公司——ETHK Inc.及ETHK HOLDINGS LIMITED，透过「ETHK」核心品牌深化全球链上金融生态战略布局；另一则是建议将公司英文名称 由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，中文双重外文名称由"华检医疗控股有限公 司"更改为"华检数字产业集团有限公司"。 9月14日，港股上市公司华检医疗(01931)连发两则公告，在资本市场掀起巨浪。 华检医疗9月14日，建议更名公告 这两则公告，标志着华检医疗正式"改头换面"，全面拥抱链上金融。其重点推动的包括"链上股票"在内 的股权资产代币化，旨在助力全球优质资产(特别是中国资产)在链上实现高效、合规的全球融通与价值 发现。 这意味着，继欧洲、美国之后，市场迎来了链上股票的"中国方案"。 一、华检医疗"改头换面"，全面拥抱链上金融 华检医疗此次的战略转型，并非一时兴起，而是经过长期布局后的全面升维。 根据公告，新成立的合资公司ETHK Inc.将专注于运营与发展「ETHK」核心品牌，旨在打造一个安 全、高效、合规、开放的去中心化金融平台。 ...

华检医疗(01931)9月14日发布两则重磅公告：一是宣布与合作方ETHK Group达成协议，共同投资成立 两家新公司ETHK Inc及ETHK HOLDINGS LIMITED；二是建议将公司英文名称由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，中文双重外文名称由"华检医疗控股有限公司"更改为"华检数字产业 集团有限公司"。 华检医疗打造的ETHK生态志在成为中国资产链上出海的高速公路，为全球资本提供一站式投资优质资 产的平台。根据公告披露的信息，ETHK生态体系构建战略包含五大支柱： 坚实的技术基础设施：兼容并深度优化以太坊等主流公链生态，同时推进自主研发的高性能区块链底层 开发与部署。 丰富的金融产品与资产矩阵：全面布局货币市场基础资产、现实世界资产代币化(RWA)，重点推动包 括"链上股票"在内的股权资产代币化。 华检医疗9月14日，设立合资公司公告 这标志着华检医疗的业务重心正式转向数字产业技术基础设施的深度研发与全球输出，从一家医疗企业 转型为链上金融生态的构建者。华检医疗的"弃医从链"战略即刻引发市场激烈辩论：这是颠覆式创新的 开始，还是资 ...

Core Viewpoint - Huajian Medical (01931) is undergoing a strategic transformation to become a digital industry technology innovator, marking a shift from a traditional medical enterprise to a focus on blockchain and decentralized finance through the establishment of new companies and a name change [1][3][4]. Group 1: Strategic Transformation - Huajian Medical has announced a partnership with ETHK Group to jointly invest in two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, aimed at developing a decentralized financial platform and a digital industry investment hub [4][6]. - The company will change its name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "Huajian Digital Industry Group Limited," reflecting its ambition to become a core technology driver in the global digital industry [3][6]. Group 2: ETHK Ecosystem - The "ETHK" brand name combines "ETH" (Ether) and "K" (Kingdom), symbolizing a vision for a decentralized financial ecosystem that aligns with blockchain technology [7]. - ETHK Labs will focus on advanced technology research and development, serving as the technological foundation and innovation engine for the ETHK ecosystem [7]. Group 3: RWA Market Opportunity - The transformation aligns with the explosive growth of the Real World Asset (RWA) market, which saw a total locked value (TVL) increase from $8.6 billion to over $23 billion in the first half of 2025, a growth of over 260% [8][9]. - Predictions indicate that the global RWA market could reach $16.1 trillion by 2030, representing 10% of global GDP, positioning Huajian Medical to lead in RWA infrastructure development [9]. Group 4: Value Reconstruction - The strategic upgrade aims to enhance China's global digital financial influence by facilitating the "on-chain" transition of quality Chinese assets [10]. - The ETHK ecosystem is expected to address financing challenges for enterprises and promote global asset integration, contributing to financial inclusivity and stability [10]. - The company's valuation model is shifting from traditional earnings-based metrics to revenue-based metrics, reflecting its new focus on digital infrastructure [10].